|
Originally published In Press as doi:10.1074/jbc.M400970200 on February 13, 2004
J. Biol. Chem., Vol. 279, Issue 17, 17319-17328, April 23, 2004
Mechanistic Relationship between Androgen Receptor Polyglutamine Tract Truncation and Androgen-dependent Transcriptional Hyperactivity in Prostate Cancer Cells*
Qianben Wang ,
T. S. Udayakumar ,
Tadas S. Vasaitis ,
Angela M. Brodie , and
Joseph D. Fondell ¶
From the
Department of Physiology and Biophysics, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854 and the Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, Maryland 21201
Androgen receptor (AR) signaling pathways mediate critical events in normal and neoplastic prostate growth. Shortening of the polymorphic N-terminal polyglutamine (poly(Q)) tract of the AR gene leads to transcriptional hyperactivity and has been correlated with an increased risk of prostate cancer. The underlying mechanisms for these effects are poorly understood. We show here that androgen-dependent cellular proliferation and transcription in prostate cancer cells is inversely correlated to the length of the AR poly(Q) region. We further show that AR proteins containing a shortened poly(Q) region functionally respond to lower concentrations of androgens than wild type AR. Whereas DNA binding activity is relatively unaffected by AR poly(Q) variation, we found that ligand binding affinity and the ligand-induced NH2- to COOH-terminal intramolecular interaction is enhanced when the poly(Q) region is shortened. Importantly, we show that AR proteins containing a shortened poly(Q) region associate in vivo with higher levels of specific p160 coactivators and components of the SWI/SNF chromatin remodeling complex as compared with the wild type AR. Collectively, our findings suggest that the AR transcriptional hyperactivity associated with shortened poly(Q) length stems from altered ligand-induced conformational changes that enhance coactivator recruitment.
Received for publication, January 28, 2004
, and in revised form, February 12, 2004.
* This work was supported by National Institutes of Health Grant DK60883 (to J. D. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 732-235-3348; Fax: 732-235-5038; E-mail: fondeljd{at}umdnj.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. Jin and J. D. Fondell
A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression
Nucleic Acids Res.,
June 11, 2009;
(2009)
gkp510v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Davies, K. Watt, S. M Kelly, C. Clark, N. C Price, and I. J McEwan
Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain
J. Mol. Endocrinol.,
November 1, 2008;
41(5):
301 - 314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Albertelli, O. A. O'Mahony, M. Brogley, J. Tosoian, M. Steinkamp, S. Daignault, K. Wojno, and D. M. Robins
Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice
Hum. Mol. Genet.,
January 1, 2008;
17(1):
98 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F Brockschmidt, M. M Nothen, and A. M Hillmer
The two most common alleles of the coding GGN repeat in the androgen receptor gene cause differences in protein function
J. Mol. Endocrinol.,
July 1, 2007;
39(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Werner, P.-M. Holterhus, G. Binder, H.-P. Schwarz, M. Morlot, D. Struve, C. Marschke, and O. Hiort
The A645D Mutation in the Hinge Region of the Human Androgen Receptor (AR) Gene Modulates AR Activity, Depending on the Context of the Polymorphic Glutamine and Glycine Repeats
J. Clin. Endocrinol. Metab.,
September 1, 2006;
91(9):
3515 - 3520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Albertelli, A. Scheller, M. Brogley, and D. M. Robins
Replacing the Mouse Androgen Receptor with Human Alleles Demonstrates Glutamine Tract Length-Dependent Effects on Physiology and Tumorigenesis in Mice
Mol. Endocrinol.,
June 1, 2006;
20(6):
1248 - 1260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alvarado, L. K. Beitel, K. Sircar, A. Aprikian, M. Trifiro, and B. Gottlieb
Somatic Mosaicism and Cancer: A Micro-Genetic Examination into the Role of the Androgen Receptor Gene in Prostate Cancer
Cancer Res.,
September 15, 2005;
65(18):
8514 - 8518.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y. Hong, J. H. Suh, K. Kim, E.-Y. Gong, S. H. Jeon, M. Ko, R. H. Seong, H. B. Kwon, and K. Lee
Modulation of Androgen Receptor Transactivation by the SWI3-Related Gene Product (SRG3) in Multiple Ways
Mol. Cell. Biol.,
June 15, 2005;
25(12):
4841 - 4852.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|